nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—PPARG—thyroid cancer	0.651	1	CbGaD
Rosiglitazone—ALB—Vandetanib—thyroid cancer	0.0722	0.331	CbGbCtD
Rosiglitazone—CYP2C8—Sorafenib—thyroid cancer	0.0336	0.154	CbGbCtD
Rosiglitazone—CYP2C19—Sorafenib—thyroid cancer	0.0282	0.129	CbGbCtD
Rosiglitazone—CYP1A2—Sorafenib—thyroid cancer	0.026	0.119	CbGbCtD
Rosiglitazone—CYP2C9—Sorafenib—thyroid cancer	0.0234	0.108	CbGbCtD
Rosiglitazone—CYP2D6—Sorafenib—thyroid cancer	0.0214	0.0984	CbGbCtD
Rosiglitazone—CYP2D6—Doxorubicin—thyroid cancer	0.013	0.0597	CbGbCtD
Rosiglitazone—Ischaemia—Sorafenib—thyroid cancer	0.00408	0.0454	CcSEcCtD
Rosiglitazone—Pioglitazone—PPARG—thyroid cancer	0.00393	1	CrCbGaD
Rosiglitazone—Visual acuity reduced—Vandetanib—thyroid cancer	0.00371	0.0413	CcSEcCtD
Rosiglitazone—Pleural effusion—Sorafenib—thyroid cancer	0.00194	0.0216	CcSEcCtD
Rosiglitazone—Myocardial ischaemia—Sorafenib—thyroid cancer	0.00185	0.0206	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Vandetanib—thyroid cancer	0.00164	0.0183	CcSEcCtD
Rosiglitazone—Cardiac failure—Vandetanib—thyroid cancer	0.00164	0.0183	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Vandetanib—thyroid cancer	0.00143	0.0159	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.00129	0.0143	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Vandetanib—thyroid cancer	0.00125	0.0139	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Sorafenib—thyroid cancer	0.00124	0.0137	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00122	0.0136	CcSEcCtD
Rosiglitazone—Hepatic failure—Sorafenib—thyroid cancer	0.0012	0.0134	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Sorafenib—thyroid cancer	0.00119	0.0132	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00117	0.013	CcSEcCtD
Rosiglitazone—Sinusitis—Vandetanib—thyroid cancer	0.00116	0.0129	CcSEcCtD
Rosiglitazone—Cardiac failure—Sorafenib—thyroid cancer	0.00111	0.0123	CcSEcCtD
Rosiglitazone—Erythema multiforme—Vandetanib—thyroid cancer	0.00105	0.0117	CcSEcCtD
Rosiglitazone—Eye disorder—Vandetanib—thyroid cancer	0.00104	0.0115	CcSEcCtD
Rosiglitazone—Cardiac disorder—Vandetanib—thyroid cancer	0.00103	0.0114	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Sorafenib—thyroid cancer	0.000966	0.0107	CcSEcCtD
Rosiglitazone—Malnutrition—Vandetanib—thyroid cancer	0.000965	0.0107	CcSEcCtD
Rosiglitazone—Hypertension—Vandetanib—thyroid cancer	0.000833	0.00926	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.000826	0.00918	CcSEcCtD
Rosiglitazone—Arthralgia—Vandetanib—thyroid cancer	0.000821	0.00913	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Sorafenib—thyroid cancer	0.000821	0.00913	CcSEcCtD
Rosiglitazone—Myocardial infarction—Sorafenib—thyroid cancer	0.000816	0.00908	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Sorafenib—thyroid cancer	0.000788	0.00876	CcSEcCtD
Rosiglitazone—Oedema—Vandetanib—thyroid cancer	0.000787	0.00875	CcSEcCtD
Rosiglitazone—Infection—Vandetanib—thyroid cancer	0.000782	0.0087	CcSEcCtD
Rosiglitazone—Nervous system disorder—Vandetanib—thyroid cancer	0.000772	0.00859	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Vandetanib—thyroid cancer	0.000771	0.00857	CcSEcCtD
Rosiglitazone—Hyperlipidaemia—Epirubicin—thyroid cancer	0.000763	0.00849	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Sorafenib—thyroid cancer	0.000735	0.00817	CcSEcCtD
Rosiglitazone—Pleural effusion—Epirubicin—thyroid cancer	0.000718	0.00799	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000717	0.00798	CcSEcCtD
Rosiglitazone—Erythema multiforme—Sorafenib—thyroid cancer	0.000707	0.00786	CcSEcCtD
Rosiglitazone—Hyperlipidaemia—Doxorubicin—thyroid cancer	0.000706	0.00785	CcSEcCtD
Rosiglitazone—Cardiac disorder—Sorafenib—thyroid cancer	0.000694	0.00771	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00068	0.00756	CcSEcCtD
Rosiglitazone—Fatigue—Vandetanib—thyroid cancer	0.000679	0.00755	CcSEcCtD
Rosiglitazone—Immune system disorder—Sorafenib—thyroid cancer	0.000675	0.00751	CcSEcCtD
Rosiglitazone—Constipation—Vandetanib—thyroid cancer	0.000673	0.00749	CcSEcCtD
Rosiglitazone—Pleural effusion—Doxorubicin—thyroid cancer	0.000665	0.00739	CcSEcCtD
Rosiglitazone—Malnutrition—Sorafenib—thyroid cancer	0.000651	0.00724	CcSEcCtD
Rosiglitazone—Hyperbilirubinaemia—Epirubicin—thyroid cancer	0.000605	0.00673	CcSEcCtD
Rosiglitazone—Anaemia—Sorafenib—thyroid cancer	0.000602	0.00669	CcSEcCtD
Rosiglitazone—Angioedema—Sorafenib—thyroid cancer	0.000595	0.00661	CcSEcCtD
Rosiglitazone—Leukopenia—Sorafenib—thyroid cancer	0.000583	0.00648	CcSEcCtD
Rosiglitazone—Asthenia—Vandetanib—thyroid cancer	0.000565	0.00628	CcSEcCtD
Rosiglitazone—Hypertension—Sorafenib—thyroid cancer	0.000562	0.00625	CcSEcCtD
Rosiglitazone—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.00056	0.00622	CcSEcCtD
Rosiglitazone—Pruritus—Vandetanib—thyroid cancer	0.000557	0.00619	CcSEcCtD
Rosiglitazone—Arthralgia—Sorafenib—thyroid cancer	0.000554	0.00616	CcSEcCtD
Rosiglitazone—Myalgia—Sorafenib—thyroid cancer	0.000554	0.00616	CcSEcCtD
Rosiglitazone—Diarrhoea—Vandetanib—thyroid cancer	0.000539	0.00599	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Sorafenib—thyroid cancer	0.000531	0.00591	CcSEcCtD
Rosiglitazone—Infection—Sorafenib—thyroid cancer	0.000528	0.00587	CcSEcCtD
Rosiglitazone—Fluid retention—Epirubicin—thyroid cancer	0.000522	0.00581	CcSEcCtD
Rosiglitazone—Nervous system disorder—Sorafenib—thyroid cancer	0.000521	0.00579	CcSEcCtD
Rosiglitazone—Dizziness—Vandetanib—thyroid cancer	0.000521	0.00579	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Sorafenib—thyroid cancer	0.00052	0.00578	CcSEcCtD
Rosiglitazone—Rash—Vandetanib—thyroid cancer	0.000496	0.00552	CcSEcCtD
Rosiglitazone—Dermatitis—Vandetanib—thyroid cancer	0.000496	0.00551	CcSEcCtD
Rosiglitazone—Headache—Vandetanib—thyroid cancer	0.000493	0.00548	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Epirubicin—thyroid cancer	0.00049	0.00545	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000484	0.00538	CcSEcCtD
Rosiglitazone—Fluid retention—Doxorubicin—thyroid cancer	0.000483	0.00537	CcSEcCtD
Rosiglitazone—Nausea—Vandetanib—thyroid cancer	0.000468	0.0052	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Epirubicin—thyroid cancer	0.000459	0.00511	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000459	0.0051	CcSEcCtD
Rosiglitazone—Fatigue—Sorafenib—thyroid cancer	0.000458	0.00509	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Epirubicin—thyroid cancer	0.000457	0.00508	CcSEcCtD
Rosiglitazone—Constipation—Sorafenib—thyroid cancer	0.000454	0.00505	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000453	0.00504	CcSEcCtD
Rosiglitazone—Hepatic failure—Epirubicin—thyroid cancer	0.000444	0.00494	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00044	0.0049	CcSEcCtD
Rosiglitazone—Increased appetite—Epirubicin—thyroid cancer	0.000425	0.00473	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000425	0.00472	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000423	0.0047	CcSEcCtD
Rosiglitazone—Urticaria—Sorafenib—thyroid cancer	0.000422	0.00469	CcSEcCtD
Rosiglitazone—Hepatic failure—Doxorubicin—thyroid cancer	0.000411	0.00457	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Epirubicin—thyroid cancer	0.000409	0.00455	CcSEcCtD
Rosiglitazone—Cardiac failure—Epirubicin—thyroid cancer	0.000409	0.00455	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000408	0.00453	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000408	0.00453	CcSEcCtD
Rosiglitazone—Increased appetite—Doxorubicin—thyroid cancer	0.000393	0.00437	CcSEcCtD
Rosiglitazone—Asthenia—Sorafenib—thyroid cancer	0.000381	0.00424	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000379	0.00421	CcSEcCtD
Rosiglitazone—Cardiac failure—Doxorubicin—thyroid cancer	0.000379	0.00421	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000377	0.00419	CcSEcCtD
Rosiglitazone—Pruritus—Sorafenib—thyroid cancer	0.000376	0.00418	CcSEcCtD
Rosiglitazone—Diarrhoea—Sorafenib—thyroid cancer	0.000363	0.00404	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Epirubicin—thyroid cancer	0.000357	0.00397	CcSEcCtD
Rosiglitazone—Dizziness—Sorafenib—thyroid cancer	0.000351	0.00391	CcSEcCtD
Rosiglitazone—Rash—Sorafenib—thyroid cancer	0.000335	0.00372	CcSEcCtD
Rosiglitazone—Dermatitis—Sorafenib—thyroid cancer	0.000335	0.00372	CcSEcCtD
Rosiglitazone—Headache—Sorafenib—thyroid cancer	0.000333	0.0037	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00033	0.00367	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000321	0.00357	CcSEcCtD
Rosiglitazone—Nausea—Sorafenib—thyroid cancer	0.000316	0.00351	CcSEcCtD
Rosiglitazone—Weight increased—Epirubicin—thyroid cancer	0.000314	0.00349	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Epirubicin—thyroid cancer	0.000311	0.00346	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000305	0.00339	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000297	0.0033	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000291	0.00324	CcSEcCtD
Rosiglitazone—Weight increased—Doxorubicin—thyroid cancer	0.000291	0.00323	CcSEcCtD
Rosiglitazone—Sinusitis—Epirubicin—thyroid cancer	0.000289	0.00321	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000288	0.0032	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000282	0.00314	CcSEcCtD
Rosiglitazone—Hepatitis—Epirubicin—thyroid cancer	0.000276	0.00307	CcSEcCtD
Rosiglitazone—Oedema peripheral—Epirubicin—thyroid cancer	0.000272	0.00303	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Epirubicin—thyroid cancer	0.000272	0.00302	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000269	0.00299	CcSEcCtD
Rosiglitazone—Sinusitis—Doxorubicin—thyroid cancer	0.000267	0.00297	CcSEcCtD
Rosiglitazone—Erythema multiforme—Epirubicin—thyroid cancer	0.000261	0.0029	CcSEcCtD
Rosiglitazone—Eye disorder—Epirubicin—thyroid cancer	0.000258	0.00287	CcSEcCtD
Rosiglitazone—Cardiac disorder—Epirubicin—thyroid cancer	0.000256	0.00285	CcSEcCtD
Rosiglitazone—Hepatitis—Doxorubicin—thyroid cancer	0.000256	0.00284	CcSEcCtD
Rosiglitazone—Oedema peripheral—Doxorubicin—thyroid cancer	0.000252	0.0028	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000251	0.00279	CcSEcCtD
Rosiglitazone—Immune system disorder—Epirubicin—thyroid cancer	0.00025	0.00277	CcSEcCtD
Rosiglitazone—Erythema multiforme—Doxorubicin—thyroid cancer	0.000242	0.00269	CcSEcCtD
Rosiglitazone—Malnutrition—Epirubicin—thyroid cancer	0.000241	0.00267	CcSEcCtD
Rosiglitazone—Eye disorder—Doxorubicin—thyroid cancer	0.000239	0.00266	CcSEcCtD
Rosiglitazone—Cardiac disorder—Doxorubicin—thyroid cancer	0.000237	0.00264	CcSEcCtD
Rosiglitazone—Back pain—Epirubicin—thyroid cancer	0.000233	0.00259	CcSEcCtD
Rosiglitazone—Immune system disorder—Doxorubicin—thyroid cancer	0.000231	0.00257	CcSEcCtD
Rosiglitazone—Malnutrition—Doxorubicin—thyroid cancer	0.000223	0.00247	CcSEcCtD
Rosiglitazone—Anaemia—Epirubicin—thyroid cancer	0.000222	0.00247	CcSEcCtD
Rosiglitazone—Leukopenia—Epirubicin—thyroid cancer	0.000215	0.00239	CcSEcCtD
Rosiglitazone—Back pain—Doxorubicin—thyroid cancer	0.000215	0.00239	CcSEcCtD
Rosiglitazone—Hypertension—Epirubicin—thyroid cancer	0.000208	0.00231	CcSEcCtD
Rosiglitazone—Anaemia—Doxorubicin—thyroid cancer	0.000206	0.00229	CcSEcCtD
Rosiglitazone—Arthralgia—Epirubicin—thyroid cancer	0.000205	0.00228	CcSEcCtD
Rosiglitazone—Myalgia—Epirubicin—thyroid cancer	0.000205	0.00228	CcSEcCtD
Rosiglitazone—Leukopenia—Doxorubicin—thyroid cancer	0.000199	0.00221	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Epirubicin—thyroid cancer	0.000196	0.00218	CcSEcCtD
Rosiglitazone—Oedema—Epirubicin—thyroid cancer	0.000196	0.00218	CcSEcCtD
Rosiglitazone—Infection—Epirubicin—thyroid cancer	0.000195	0.00217	CcSEcCtD
Rosiglitazone—Nervous system disorder—Epirubicin—thyroid cancer	0.000193	0.00214	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Epirubicin—thyroid cancer	0.000192	0.00214	CcSEcCtD
Rosiglitazone—Hypertension—Doxorubicin—thyroid cancer	0.000192	0.00214	CcSEcCtD
Rosiglitazone—Arthralgia—Doxorubicin—thyroid cancer	0.000189	0.00211	CcSEcCtD
Rosiglitazone—Myalgia—Doxorubicin—thyroid cancer	0.000189	0.00211	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000182	0.00202	CcSEcCtD
Rosiglitazone—Oedema—Doxorubicin—thyroid cancer	0.000182	0.00202	CcSEcCtD
Rosiglitazone—Infection—Doxorubicin—thyroid cancer	0.00018	0.00201	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000179	0.00199	CcSEcCtD
Rosiglitazone—Nervous system disorder—Doxorubicin—thyroid cancer	0.000178	0.00198	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000178	0.00198	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000169	0.00188	CcSEcCtD
Rosiglitazone—Fatigue—Epirubicin—thyroid cancer	0.000169	0.00188	CcSEcCtD
Rosiglitazone—Constipation—Epirubicin—thyroid cancer	0.000168	0.00187	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000165	0.00184	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000157	0.00174	CcSEcCtD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000157	0.00424	CbGpPWpGaD
Rosiglitazone—Fatigue—Doxorubicin—thyroid cancer	0.000157	0.00174	CcSEcCtD
Rosiglitazone—Urticaria—Epirubicin—thyroid cancer	0.000156	0.00173	CcSEcCtD
Rosiglitazone—Constipation—Doxorubicin—thyroid cancer	0.000155	0.00173	CcSEcCtD
Rosiglitazone—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000155	0.00419	CbGpPWpGaD
Rosiglitazone—Urticaria—Doxorubicin—thyroid cancer	0.000144	0.0016	CcSEcCtD
Rosiglitazone—PPARG—Regulation of retinoblastoma protein—CCND1—thyroid cancer	0.000142	0.00385	CbGpPWpGaD
Rosiglitazone—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	0.000142	0.00385	CbGpPWpGaD
Rosiglitazone—Asthenia—Epirubicin—thyroid cancer	0.000141	0.00157	CcSEcCtD
Rosiglitazone—Pruritus—Epirubicin—thyroid cancer	0.000139	0.00154	CcSEcCtD
Rosiglitazone—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000138	0.00374	CbGpPWpGaD
Rosiglitazone—PTGS1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000138	0.00373	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—HIF1A—thyroid cancer	0.000137	0.00371	CbGpPWpGaD
Rosiglitazone—Diarrhoea—Epirubicin—thyroid cancer	0.000134	0.00149	CcSEcCtD
Rosiglitazone—SLCO1B1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000133	0.00359	CbGpPWpGaD
Rosiglitazone—SLCO1B1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000133	0.00359	CbGpPWpGaD
Rosiglitazone—CYP2A6—NRF2 pathway—SLC5A5—thyroid cancer	0.000133	0.00359	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—TPR—thyroid cancer	0.000131	0.00354	CbGpPWpGaD
Rosiglitazone—Asthenia—Doxorubicin—thyroid cancer	0.00013	0.00145	CcSEcCtD
Rosiglitazone—Dizziness—Epirubicin—thyroid cancer	0.00013	0.00144	CcSEcCtD
Rosiglitazone—ACSL4—Metabolism—PRKAR1A—thyroid cancer	0.000129	0.00348	CbGpPWpGaD
Rosiglitazone—Pruritus—Doxorubicin—thyroid cancer	0.000129	0.00143	CcSEcCtD
Rosiglitazone—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000127	0.00344	CbGpPWpGaD
Rosiglitazone—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000126	0.00341	CbGpPWpGaD
Rosiglitazone—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000126	0.0034	CbGpPWpGaD
Rosiglitazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000125	0.0034	CbGpPWpGaD
Rosiglitazone—Diarrhoea—Doxorubicin—thyroid cancer	0.000124	0.00138	CcSEcCtD
Rosiglitazone—Rash—Epirubicin—thyroid cancer	0.000124	0.00138	CcSEcCtD
Rosiglitazone—Dermatitis—Epirubicin—thyroid cancer	0.000124	0.00137	CcSEcCtD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000123	0.00334	CbGpPWpGaD
Rosiglitazone—Headache—Epirubicin—thyroid cancer	0.000123	0.00137	CcSEcCtD
Rosiglitazone—Dizziness—Doxorubicin—thyroid cancer	0.00012	0.00134	CcSEcCtD
Rosiglitazone—Nausea—Epirubicin—thyroid cancer	0.000117	0.0013	CcSEcCtD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000116	0.00315	CbGpPWpGaD
Rosiglitazone—Rash—Doxorubicin—thyroid cancer	0.000115	0.00127	CcSEcCtD
Rosiglitazone—Dermatitis—Doxorubicin—thyroid cancer	0.000114	0.00127	CcSEcCtD
Rosiglitazone—Headache—Doxorubicin—thyroid cancer	0.000114	0.00127	CcSEcCtD
Rosiglitazone—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000112	0.00304	CbGpPWpGaD
Rosiglitazone—CYP2A6—NRF2 pathway—RXRA—thyroid cancer	0.000111	0.00301	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00011	0.00297	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—MINPP1—thyroid cancer	0.000108	0.00293	CbGpPWpGaD
Rosiglitazone—CYP2A6—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000108	0.00293	CbGpPWpGaD
Rosiglitazone—Nausea—Doxorubicin—thyroid cancer	0.000108	0.0012	CcSEcCtD
Rosiglitazone—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000108	0.00292	CbGpPWpGaD
Rosiglitazone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000107	0.0029	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—TRIM33—thyroid cancer	0.000106	0.00286	CbGpPWpGaD
Rosiglitazone—PTGS1—Biological oxidations—RXRA—thyroid cancer	0.000103	0.0028	CbGpPWpGaD
Rosiglitazone—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000103	0.00279	CbGpPWpGaD
Rosiglitazone—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000102	0.00277	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—MEN1—thyroid cancer	0.000101	0.00273	CbGpPWpGaD
Rosiglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	9.93e-05	0.00269	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—SLC5A5—thyroid cancer	9.78e-05	0.00265	CbGpPWpGaD
Rosiglitazone—CYP2A6—Biological oxidations—RXRA—thyroid cancer	9.77e-05	0.00264	CbGpPWpGaD
Rosiglitazone—CYP2A6—NRF2 pathway—NRG1—thyroid cancer	9.63e-05	0.00261	CbGpPWpGaD
Rosiglitazone—PPARG—Wnt Signaling Pathway Netpath—AKT1—thyroid cancer	9.58e-05	0.00259	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—NDUFA13—thyroid cancer	9.21e-05	0.00249	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.16e-05	0.00248	CbGpPWpGaD
Rosiglitazone—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	8.9e-05	0.00241	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—PTGS2—thyroid cancer	8.77e-05	0.00237	CbGpPWpGaD
Rosiglitazone—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	8.74e-05	0.00237	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—CHST14—thyroid cancer	8.66e-05	0.00234	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—MINPP1—thyroid cancer	8.53e-05	0.00231	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—RXRA—thyroid cancer	8.22e-05	0.00222	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.99e-05	0.00216	CbGpPWpGaD
Rosiglitazone—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	7.95e-05	0.00215	CbGpPWpGaD
Rosiglitazone—PPARG—SREBP signalling—AKT1—thyroid cancer	7.64e-05	0.00207	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—THRB—thyroid cancer	7.63e-05	0.00207	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—MINPP1—thyroid cancer	7.59e-05	0.00205	CbGpPWpGaD
Rosiglitazone—ALB—SLC-mediated transmembrane transport—CP—thyroid cancer	7.58e-05	0.00205	CbGpPWpGaD
Rosiglitazone—ALB—SLC-mediated transmembrane transport—TPR—thyroid cancer	7.58e-05	0.00205	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—NDUFA13—thyroid cancer	7.25e-05	0.00196	CbGpPWpGaD
Rosiglitazone—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	7.25e-05	0.00196	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—MINPP1—thyroid cancer	7.18e-05	0.00194	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	7.09e-05	0.00192	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	7.05e-05	0.00191	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—HPGD—thyroid cancer	6.98e-05	0.00189	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—CDK1—thyroid cancer	6.83e-05	0.00185	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CHST14—thyroid cancer	6.82e-05	0.00185	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—CP—thyroid cancer	6.74e-05	0.00182	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—TPR—thyroid cancer	6.74e-05	0.00182	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—RXRA—thyroid cancer	6.74e-05	0.00182	CbGpPWpGaD
Rosiglitazone—CYP2C8—Biological oxidations—RXRA—thyroid cancer	6.67e-05	0.00181	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	6.63e-05	0.0018	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	6.62e-05	0.00179	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—NDUFA13—thyroid cancer	6.45e-05	0.00175	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—RXRA—thyroid cancer	6.34e-05	0.00172	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	6.33e-05	0.00171	CbGpPWpGaD
Rosiglitazone—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	6.19e-05	0.00168	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—NDUFA13—thyroid cancer	6.1e-05	0.00165	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CHST14—thyroid cancer	6.07e-05	0.00164	CbGpPWpGaD
Rosiglitazone—CYP2C19—Biological oxidations—RXRA—thyroid cancer	5.96e-05	0.00161	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5.77e-05	0.00156	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CHST14—thyroid cancer	5.74e-05	0.00155	CbGpPWpGaD
Rosiglitazone—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	5.67e-05	0.00154	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.66e-05	0.00153	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—PTEN—thyroid cancer	5.64e-05	0.00153	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	5.63e-05	0.00152	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—HPGD—thyroid cancer	5.5e-05	0.00149	CbGpPWpGaD
Rosiglitazone—CYP2D6—Biological oxidations—RXRA—thyroid cancer	5.48e-05	0.00148	CbGpPWpGaD
Rosiglitazone—CYP2C9—Biological oxidations—RXRA—thyroid cancer	5.43e-05	0.00147	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—PPARG—thyroid cancer	5.19e-05	0.0014	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—TPR—thyroid cancer	5.16e-05	0.0014	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	5.15e-05	0.00139	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.05e-05	0.00137	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	4.93e-05	0.00134	CbGpPWpGaD
Rosiglitazone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	4.93e-05	0.00133	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—MINPP1—thyroid cancer	4.9e-05	0.00133	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—HPGD—thyroid cancer	4.89e-05	0.00132	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—MINPP1—thyroid cancer	4.87e-05	0.00132	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MEN1—thyroid cancer	4.85e-05	0.00131	CbGpPWpGaD
Rosiglitazone—CYP1A2—Biological oxidations—RXRA—thyroid cancer	4.64e-05	0.00126	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—HPGD—thyroid cancer	4.62e-05	0.00125	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.46e-05	0.00121	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	4.43e-05	0.0012	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PRKAR1A—thyroid cancer	4.38e-05	0.00118	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—MINPP1—thyroid cancer	4.38e-05	0.00118	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.24e-05	0.00115	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—TP53—thyroid cancer	4.22e-05	0.00114	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—NDUFA13—thyroid cancer	4.17e-05	0.00113	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—NDUFA13—thyroid cancer	4.14e-05	0.00112	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—PTGS2—thyroid cancer	4.08e-05	0.0011	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—MINPP1—thyroid cancer	4.02e-05	0.00109	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—TPR—thyroid cancer	4.01e-05	0.00109	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—MINPP1—thyroid cancer	3.99e-05	0.00108	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.97e-05	0.00107	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PRKAR1A—thyroid cancer	3.94e-05	0.00107	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CHST14—thyroid cancer	3.92e-05	0.00106	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CHST14—thyroid cancer	3.9e-05	0.00105	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	3.85e-05	0.00104	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	3.85e-05	0.00104	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—TP53—thyroid cancer	3.85e-05	0.00104	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.79e-05	0.00103	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	3.77e-05	0.00102	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NDUFA13—thyroid cancer	3.72e-05	0.00101	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—PTEN—thyroid cancer	3.56e-05	0.000964	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CHST14—thyroid cancer	3.5e-05	0.000947	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NDUFA13—thyroid cancer	3.42e-05	0.000926	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—MINPP1—thyroid cancer	3.41e-05	0.000923	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NDUFA13—thyroid cancer	3.39e-05	0.000918	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—RXRA—thyroid cancer	3.24e-05	0.000878	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CHST14—thyroid cancer	3.22e-05	0.000871	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CHST14—thyroid cancer	3.19e-05	0.000863	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—HPGD—thyroid cancer	3.16e-05	0.000855	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—TPR—thyroid cancer	3.16e-05	0.000855	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—HPGD—thyroid cancer	3.14e-05	0.00085	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	3.11e-05	0.000841	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—SLC5A5—thyroid cancer	3e-05	0.000813	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—IFNA2—thyroid cancer	2.9e-05	0.000785	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NDUFA13—thyroid cancer	2.9e-05	0.000785	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.88e-05	0.000781	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—HPGD—thyroid cancer	2.82e-05	0.000763	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.82e-05	0.000762	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.81e-05	0.000761	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—TPR—thyroid cancer	2.81e-05	0.00076	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PRKAR1A—thyroid cancer	2.76e-05	0.000748	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CHST14—thyroid cancer	2.73e-05	0.000738	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—TPR—thyroid cancer	2.66e-05	0.000719	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	2.61e-05	0.000707	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—HPGD—thyroid cancer	2.59e-05	0.000702	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—HPGD—thyroid cancer	2.57e-05	0.000696	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.56e-05	0.000694	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.55e-05	0.00069	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—RXRA—thyroid cancer	2.52e-05	0.000683	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.5e-05	0.000678	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.45e-05	0.000664	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—NRAS—thyroid cancer	2.45e-05	0.000663	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.42e-05	0.000656	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	2.36e-05	0.00064	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.29e-05	0.000619	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.21e-05	0.0006	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HPGD—thyroid cancer	2.2e-05	0.000595	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—KRAS—thyroid cancer	2.11e-05	0.000571	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—SLC5A5—thyroid cancer	2.1e-05	0.000569	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.09e-05	0.000565	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—AKT1—thyroid cancer	2.05e-05	0.000555	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—SLC5A5—thyroid cancer	1.99e-05	0.000538	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—RXRA—thyroid cancer	1.99e-05	0.000538	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.97e-05	0.000533	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.93e-05	0.000523	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—TPR—thyroid cancer	1.81e-05	0.000491	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—TPR—thyroid cancer	1.8e-05	0.000488	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—HRAS—thyroid cancer	1.79e-05	0.000485	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.78e-05	0.000483	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.78e-05	0.000482	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PRKAR1A—thyroid cancer	1.77e-05	0.00048	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—RXRA—thyroid cancer	1.77e-05	0.000478	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.72e-05	0.000465	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—RXRA—thyroid cancer	1.67e-05	0.000452	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—TPR—thyroid cancer	1.62e-05	0.000438	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.62e-05	0.000438	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.61e-05	0.000435	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.59e-05	0.000431	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—AKT1—thyroid cancer	1.58e-05	0.000428	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—TPR—thyroid cancer	1.49e-05	0.000403	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—TPR—thyroid cancer	1.48e-05	0.0004	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.47e-05	0.000397	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.45e-05	0.000393	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.44e-05	0.000391	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.36e-05	0.000368	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	1.36e-05	0.000367	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SLC5A5—thyroid cancer	1.35e-05	0.000366	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.32e-05	0.000356	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.27e-05	0.000345	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.27e-05	0.000343	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—TPR—thyroid cancer	1.26e-05	0.000342	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PPARG—thyroid cancer	1.25e-05	0.000339	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTGS2—thyroid cancer	1.25e-05	0.000339	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.24e-05	0.000336	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.21e-05	0.000328	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—RXRA—thyroid cancer	1.14e-05	0.000309	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.14e-05	0.000308	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—RXRA—thyroid cancer	1.13e-05	0.000307	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.13e-05	0.000305	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PPARG—thyroid cancer	1.12e-05	0.000302	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.11e-05	0.000302	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.11e-05	0.0003	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.11e-05	0.000299	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.1e-05	0.000299	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTEN—thyroid cancer	1.09e-05	0.000296	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—NRAS—thyroid cancer	1.08e-05	0.000293	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PPARG—thyroid cancer	1.05e-05	0.000286	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.04e-05	0.00028	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—RXRA—thyroid cancer	1.02e-05	0.000276	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.91e-06	0.000268	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTGS2—thyroid cancer	9.86e-06	0.000267	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC5A5—thyroid cancer	9.44e-06	0.000256	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—RXRA—thyroid cancer	9.37e-06	0.000254	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—KRAS—thyroid cancer	9.31e-06	0.000252	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—RXRA—thyroid cancer	9.29e-06	0.000251	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.03e-06	0.000245	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.85e-06	0.00024	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTGS2—thyroid cancer	8.77e-06	0.000238	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTEN—thyroid cancer	8.6e-06	0.000233	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS2—thyroid cancer	8.3e-06	0.000225	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TP53—thyroid cancer	8.27e-06	0.000224	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—AKT1—thyroid cancer	8.1e-06	0.000219	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—RXRA—thyroid cancer	7.94e-06	0.000215	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—HRAS—thyroid cancer	7.91e-06	0.000214	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.72e-06	0.000209	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTEN—thyroid cancer	7.65e-06	0.000207	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTEN—thyroid cancer	7.24e-06	0.000196	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPARG—thyroid cancer	7.2e-06	0.000195	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPARG—thyroid cancer	7.16e-06	0.000194	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—AKT1—thyroid cancer	6.99e-06	0.000189	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPARG—thyroid cancer	6.43e-06	0.000174	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—AKT1—thyroid cancer	6.29e-06	0.00017	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPARG—thyroid cancer	5.91e-06	0.00016	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPARG—thyroid cancer	5.86e-06	0.000159	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS2—thyroid cancer	5.67e-06	0.000153	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS2—thyroid cancer	5.64e-06	0.000153	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS2—thyroid cancer	5.06e-06	0.000137	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPARG—thyroid cancer	5.01e-06	0.000136	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AKT1—thyroid cancer	4.96e-06	0.000134	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTEN—thyroid cancer	4.94e-06	0.000134	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTEN—thyroid cancer	4.91e-06	0.000133	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS2—thyroid cancer	4.65e-06	0.000126	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS2—thyroid cancer	4.61e-06	0.000125	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTEN—thyroid cancer	4.41e-06	0.000119	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AKT1—thyroid cancer	4.41e-06	0.000119	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AKT1—thyroid cancer	4.17e-06	0.000113	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTEN—thyroid cancer	4.06e-06	0.00011	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTEN—thyroid cancer	4.02e-06	0.000109	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS2—thyroid cancer	3.94e-06	0.000107	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTEN—thyroid cancer	3.44e-06	9.31e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AKT1—thyroid cancer	2.85e-06	7.71e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AKT1—thyroid cancer	2.83e-06	7.67e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AKT1—thyroid cancer	2.54e-06	6.88e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AKT1—thyroid cancer	2.34e-06	6.33e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AKT1—thyroid cancer	2.32e-06	6.28e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AKT1—thyroid cancer	1.98e-06	5.36e-05	CbGpPWpGaD
